JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.11% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
iShares US Healthcare ETF
IYH
$3.77B
| $13.4M | ﹤0.01% |
230,264
+26,286
| +13% | +$1.62M |
|
2377
PUT
lululemon athletica
LULU
$13.6B
| $13.4M | ﹤0.01% |
35,000
-2,900
| -8% | -$947K |
|
2378
CALL
Valero Energy
VLO
$98.7B
| $13.4M | ﹤0.01% |
109,100
-58,000
| -35% | -$7.76M |
|
2379
PUT
Chevron
CVX
$388B
| $13.4M | ﹤0.01% |
92,300
-32,300
| -26% | -$4.94M |
|
2380
HUB Group
HUBG
$2.46B
| $13.4M | ﹤0.01% |
299,634
+117,047
| +64% | +$5.46M |
|
2381
SSR Mining
SSRM
$6.49B
| $13.4M | ﹤0.01% |
1,918,258
+370,006
| +24% | +$2.3M |
|
2382
Apogee Enterprises
APOG
$897M
| $13.3M | ﹤0.01% |
186,744
+87,356
| +88% | +$6.86M |
|
2383
Vir Biotechnology
VIR
$1.52B
| $13.3M | ﹤0.01% |
1,807,017
+720,690
| +66% | +$5.68M |
|
2384
CALL
Constellation Brands
STZ
$22.9B
| $13.3M | ﹤0.01% |
60,000
| – | – |
|
2385
Axcelis
ACLS
$4.39B
| $13.2M | ﹤0.01% |
189,568
+10,645
| +6% | +$884K |
|
|
PGRE
2386
DELISTED
Paramount Group
PGRE
| $13.2M | ﹤0.01% |
2,678,713
+160,884
| +6% | +$795K |
|
2387
CALL
Yum China
YUMC
$16.2B
| $13.2M | ﹤0.01% |
273,400
-5,900
| -2% | -$280K |
|
2388
ADMA Biologics
ADMA
$2.11B
| $13.2M | ﹤0.01% |
767,265
+561,310
| +273% | +$10.6M |
|
|
APLS
2389
DELISTED
Apellis Pharmaceuticals
APLS
| $13.1M | ﹤0.01% |
411,549
-3,473,181
| -89% | -$104M |
|
2390
ATI
ATI
$31.4B
| $13.1M | ﹤0.01% |
238,461
-44,799
| -16% | -$2.64M |
|
2391
United Microelectronic
UMC
$48.6B
| $13.1M | ﹤0.01% |
2,021,849
+1,215,849
| +151% | +$8.7M |
|
2392
CVB Financial
CVBF
$4.05B
| $13.1M | ﹤0.01% |
612,503
+249,009
| +69% | +$5.27M |
|
2393
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $13.1M | ﹤0.01% |
114,518
+1,712
| +2% | +$206K |
|
2394
Corcept Therapeutics
CORT
$12.1B
| $13.1M | ﹤0.01% |
259,902
+6,832
| +3% | +$358K |
|
2395
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $13.1M | ﹤0.01% |
129,585
+42,948
| +50% | +$4.43M |
|
|
RNAM
2396
DELISTED
Avidity Biosciences
RNAM
| $13.1M | ﹤0.01% |
450,144
-16,941
| -4% | -$708K |
|
2397
Acadia Pharmaceuticals
ACAD
$5.07B
| $13.1M | ﹤0.01% |
713,360
+272,236
| +62% | +$4.39M |
|
2398
Blackstone Mortgage Trust
BXMT
$2.41B
| $13.1M | ﹤0.01% |
751,668
+364,699
| +94% | +$6.74M |
|
|
ECHO
2399
EchoStar
ECHO
$26.6B
| $13M | ﹤0.01% |
569,028
+297,424
| +110% | +$7.2M |
|
|
KLC
2400
KinderCare Learning Companies
KLC
$550M
| $13M | ﹤0.01% |
+730,571
| New | +$17.5M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.